Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 241,417 |
|
|||||
| News | - | ||||||
| Day High | 10.81 | Low High |
|||||
| Day Low | 10.26 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| KalVista Pharmaceuticals Inc | KALV | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.29 | 2.76% | 10.78 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.50 | 10.26 | 10.81 | 10.78 | 10.49 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,225 | 241,417 | US$ 10.65 | US$ 2,569,924 | - | 7.21 - 16.88 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:01 | formt | 246 | US$ 10.78 | USD |
KalVista Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 454.79M | 42.19M | - | 0 | -92.91M | -2.20 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
KalVista Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KALV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.42 | 11.78 | 10.105 | 10.92 | 334,960 | -0.64 | -5.60% |
| 1 Month | 11.86 | 12.26 | 10.105 | 11.37 | 435,151 | -1.08 | -9.11% |
| 3 Months | 15.56 | 16.8793 | 10.105 | 13.42 | 821,975 | -4.78 | -30.72% |
| 6 Months | 7.91 | 16.88 | 7.21 | 12.62 | 582,429 | 2.87 | 36.28% |
| 1 Year | 8.02 | 16.88 | 7.21 | 11.81 | 406,275 | 2.76 | 34.41% |
| 3 Years | 24.61 | 30.70 | 4.12 | 12.04 | 314,550 | -13.83 | -56.20% |
| 5 Years | 24.97 | 45.00 | 4.12 | 16.53 | 288,993 | -14.19 | -56.83% |
KalVista Pharmaceuticals Description
| KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. |
